Oncolytics Biotech buy Raymond James
Start price
04.04.24
/
50%
€1.61
Target price
04.04.25
€2.76
Performance (%)
-
End price
05.04.25
-
Summary
This prediction was cancelled by the user.Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Oncolytics Biotech | - | - | - |
| iShares Core DAX® | 3.258% | 2.069% | 10.102% |
| iShares Nasdaq 100 | 5.697% | -0.604% | 28.972% |
| iShares Nikkei 225® | 7.770% | -4.746% | 52.094% |
| iShares S&P 500 | 2.795% | 2.251% | 23.747% |
Comments by Raymond_James for this prediction
In the thread Oncolytics Biotech diskutieren
Oncolytics Biotech Inc. (NASDAQ: ONCY) is now covered by analysts at Raymond James. They set an "outperform" rating and a $3.00 price target on the stock.
Ratings data for ONCY provided by MarketBeat
In the thread Trading Oncolytics Biotech
Die von Raymond_James gewählte maximale Laufzeit wurde überschritten